Mikki Koo

Mikki has been the Global Health Policy Lead for Roche Diagnostic International since 2019 where she represents Roche Diagnostics in various MedTechEurope working groups including the MTE CVD working group.

She has over 15 years of experience in the life science and diagnostic industry living and working across multiple geographies.

Prior to joining Roche Diagnostics International, Mikki held various business development roles where the focus was ensuring access to diagnostics in health systems.

Prior to joining the industry, Mikki worked as a postdoctoral research fellow in the field of oncology at the National University of Singapore.

Mikki holds a Msc in Health Economics, Health Policy and Health Management from the London School of Economics and Political Science and a PhD in Biochemistry from the University of Bath, UK.

With Europe's ageing population comes several social, economic and environmental benefits. It also brings rising risks of cardiovascular disease (CVD) which must be managed to protect citizens’ wellbeing and the sustainability of our health systems. That is why we are inspired to see 15 European and international health organisations joining forces to form the European Alliance for Cardiovascular Health. Their shared goal is to call on the European Union to set out an ambitious plan of action to tackle the burden of CVD. There is no time to lose. CVD is the leading cause of death in Europe, affecting millions of lives every day. This group of conditions includes heart attacks and strokes, heart failure as well as arrhythmias and congenital heart disease – all of which can have a profound impact on quality of life. So, what do we need to do together to ensure that Europe takes the right actions today to reduce the burden on individuals and society in the future? The vital role of secondary prevention Along with better care and rehabilitation, one of the key messages emerging from the launch of the Alliance is on prevention. This includes secondary prevention to reduce the risk of having a second cardiac event and to manage the health of CVD patients. This struck a chord with us given our work on heart failure. The human heart is like a pump. Its task is to deliver oxygen and nutrients to all cells in the body, as well as removing waste via the bloodstream. Heart failure occurs when the heart’s pumping capacity is reduced, and it can no longer deliver enough blood to meet the body’s needs. This life-threatening disease affects millions of patients for whom the outlook is often poor. It is associated with hospitalisation and early death. For...